AAAAAA

   
Results: 1-20 |
Results: 20
CD95-mediated apoptosis of human glioma cells: Modulation by epidermal growth factor receptor activity
Authors: Steinbach, JP Supra, P Huang, HJS Cavenee, WK Weller, M
Citation: Jp. Steinbach et al., CD95-mediated apoptosis of human glioma cells: Modulation by epidermal growth factor receptor activity, BRAIN PATH, 12(1), 2002, pp. 12-20
The potential of TRAIL for cancer chemotherapy
Authors: Nagane, M Huang, HJS Cavenee, WK
Citation: M. Nagane et al., The potential of TRAIL for cancer chemotherapy, APOPTOSIS, 6(3), 2001, pp. 191-197
Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor
Authors: Nagane, M Narita, Y Mishima, K Levitzki, A Burgess, AW Cavenee, WK Huang, HJS
Citation: M. Nagane et al., Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor, J NEUROSURG, 95(3), 2001, pp. 472-479
The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor
Authors: Klingler-Hoffmann, M Fodero-Tavoletti, MT Mishima, K Narita, Y Cavenee, WK Furnari, FB Huang, HJS Tiganis, T
Citation: M. Klingler-hoffmann et al., The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor, J BIOL CHEM, 276(49), 2001, pp. 46313-46318
Vascular endothelial growth factor isoforms display distinct activities inpromoting tumor angiogenesis at different anatomic sites
Authors: Guo, P Xu, L Pan, S Brekken, RA Yang, ST Whitaker, GB Nagane, M Thorpe, PE Rosenbaum, JS Huang, HJS Cavenee, WK Cheng, SY
Citation: P. Guo et al., Vascular endothelial growth factor isoforms display distinct activities inpromoting tumor angiogenesis at different anatomic sites, CANCER RES, 61(23), 2001, pp. 8569-8577
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor (vol 61, pg 5349, 2001)
Authors: Mishima, K Johns, TG Luwor, RB Scott, AM Stockert, E Jungbluth, AA Ji, XD Suvarna, P Voland, JR Old, LJ Huang, HJS Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor (vol 61, pg 5349, 2001), CANCER RES, 61(20), 2001, pp. 7703-7703
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor
Authors: Mishima, K Johns, TG Luwor, RB Scott, AM Stockert, E Jungbluth, AA Ji, XD Suvarna, P Voland, JR Old, LJ Huang, HJS Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor, CANCER RES, 61(14), 2001, pp. 5349-5354
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR
Authors: Luwor, RB Johns, TG Murone, C Huang, HJS Cavenee, WK Ritter, G Old, LJ Burgess, AW Scott, AM
Citation: Rb. Luwor et al., Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR, CANCER RES, 61(14), 2001, pp. 5355-5361
SETA: A novel SH3 domain-containing adapter molecule associated with malignancy in astrocytes
Authors: Bogler, O Furnari, FB Kindler-Roehrborn, A Sykes, VW Yung, R Huang, HJS Cavenee, WK
Citation: O. Bogler et al., SETA: A novel SH3 domain-containing adapter molecule associated with malignancy in astrocytes, NEURO-ONCOL, 2(1), 2000, pp. 6-15
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
Authors: Costello, JF Fruhwald, MC Smiraglia, DJ Rush, LJ Robertson, GP Gao, X Wright, FA Feramisco, JD Peltomaki, P Lang, JC Schuller, DE Yu, L Bloomfield, CD Caligiuri, MA Yates, A Nishikawa, R Huang, HJS Petrelli, NJ Zhang, XL O'Dorisio, MS Held, WA Cavenee, WK Plass, C
Citation: Jf. Costello et al., Aberrant CpG-island methylation has non-random and tumour-type-specific patterns, NAT GENET, 24(2), 2000, pp. 132-138
Analysis of the p300/CBP-Associated Factor (PCAF) gene in astrocytic tumors
Authors: Nishimori, H Nishikawa, R Fujimaki, T Nakagomi, T Matsutani, M Huang, HJS Cavenee, WK
Citation: H. Nishimori et al., Analysis of the p300/CBP-Associated Factor (PCAF) gene in astrocytic tumors, J NEURO-ONC, 46(1), 2000, pp. 17-22
A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin
Authors: Mishima, K Mazar, AP Gown, A Skelly, M Ji, XD Wang, XD Jones, TR Cavenee, WK Huang, HJS
Citation: K. Mishima et al., A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin, P NAS US, 97(15), 2000, pp. 8484-8489
Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
Authors: Nagane, M Pan, GH Weddle, JJ Dixit, VM Cavenee, WK Huang, HJS
Citation: M. Nagane et al., Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo, CANCER RES, 60(4), 2000, pp. 847-853
Causes of drug resistance and novel therapeutic opportunities for the treatment of glioblastoma
Authors: Nagane, M Huang, HJS Cavenee, WK
Citation: M. Nagane et al., Causes of drug resistance and novel therapeutic opportunities for the treatment of glioblastoma, DRUG RESIST, 2(1), 1999, pp. 30-37
Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro
Authors: Bogler, O Nagane, M Gillis, J Huang, HJS Cavenee, WK
Citation: O. Bogler et al., Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro, CELL GROWTH, 10(2), 1999, pp. 73-86
Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase
Authors: Wang, DG Huang, HJS Kazlauskas, A Cavenee, WK
Citation: Dg. Wang et al., Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase, CANCER RES, 59(7), 1999, pp. 1464-1472
Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis
Authors: Valter, MM Hugel, A Huang, HJS Cavenee, WK Wiestler, OD Pietsch, T Wernert, N
Citation: Mm. Valter et al., Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis, CANCER RES, 59(21), 1999, pp. 5608-5614
The chromosome 10 monosomy common in human melanomas results from the lossof two separate tumor suppressor loci
Authors: Robertson, GP Herbst, RA Nagane, M Huang, HJS Cavenee, WK
Citation: Gp. Robertson et al., The chromosome 10 monosomy common in human melanomas results from the lossof two separate tumor suppressor loci, CANCER RES, 59(15), 1999, pp. 3596-3601
Vascular endothelial growth factor (VEGF) likely contributes to oligodendroglioma angiogenesis - Reply
Authors: Nishikawa, R Matsutani, M Cheng, SY Huang, HJS Cavenee, WC
Citation: R. Nishikawa et al., Vascular endothelial growth factor (VEGF) likely contributes to oligodendroglioma angiogenesis - Reply, ACT NEUROP, 97(4), 1999, pp. 431-432
Expression of integrin transcripts in human cancer cells
Authors: Arap, W Huang, HJS
Citation: W. Arap et Hjs. Huang, Expression of integrin transcripts in human cancer cells, METH MOL B, 129, 1999, pp. 91-101
Risultati: 1-20 |